X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (921) 921
Publication (71) 71
Book Review (4) 4
Conference Proceeding (4) 4
Data Set (2) 2
Book Chapter (1) 1
Magazine Article (1) 1
Paper (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (588) 588
pharmacology & pharmacy (523) 523
animals (509) 509
poloxamer - chemistry (482) 482
humans (340) 340
male (255) 255
poloxamer (233) 233
drug delivery systems (199) 199
nanoparticles (189) 189
rats (184) 184
female (180) 180
particle size (180) 180
mice (175) 175
drug carriers - chemistry (158) 158
solubility (149) 149
drug-delivery (136) 136
temperature (131) 131
micelles (125) 125
gels (120) 120
delivery (113) 113
chemistry, medicinal (105) 105
in-vitro (103) 103
nanoparticles - chemistry (102) 102
cell line, tumor (98) 98
chemistry, multidisciplinary (98) 98
drugs (95) 95
rats, sprague-dawley (95) 95
release (92) 92
chemistry, pharmaceutical (91) 91
poloxamer - pharmacology (91) 91
hydrogels (90) 90
cancer (88) 88
poloxamer - therapeutic use (88) 88
nanoscience & nanotechnology (87) 87
poloxamer 407 (87) 87
biological availability (84) 84
drug stability (80) 80
bioavailability (79) 79
formulation (77) 77
polymers (77) 77
excipients - chemistry (76) 76
poloxamer - administration & dosage (76) 76
rabbits (71) 71
cell survival - drug effects (68) 68
permeability (68) 68
vehicles (68) 68
viscosity (67) 67
polymers - chemistry (65) 65
in-vivo (64) 64
pharmacy (64) 64
analysis (63) 63
drug compounding (63) 63
medicine (62) 62
poloxamer 188 (62) 62
rheology (62) 62
block-copolymers (61) 61
pharmacokinetics (60) 60
research (60) 60
materials science, biomaterials (56) 56
delayed-action preparations (54) 54
drug delivery systems - methods (54) 54
pluronic (54) 54
polyethylene glycols - chemistry (54) 54
surface-active agents - chemistry (53) 53
drug carriers (51) 51
poly (51) 51
disease models, animal (50) 50
time factors (50) 50
administration, oral (49) 49
cells (49) 49
chemistry, pharmaceutical - methods (49) 49
original research (49) 49
drug liberation (48) 48
microspheres (48) 48
stability (48) 48
formulations (47) 47
absorption (46) 46
mice, inbred balb c (46) 46
article (44) 44
care and treatment (44) 44
doxorubicin (44) 44
gels - chemistry (44) 44
antineoplastic agents - administration & dosage (43) 43
rats, wistar (43) 43
systems (43) 43
engineering, biomedical (42) 42
health aspects (42) 42
chemotherapy (41) 41
drug (41) 41
hydrogen-ion concentration (41) 41
kinetics (41) 41
surface properties (41) 41
cytotoxicity (40) 40
delayed-action preparations - chemistry (40) 40
drug delivery (40) 40
in vitro techniques (40) 40
poloxamer - pharmacokinetics (40) 40
biotechnology & applied microbiology (39) 39
pluronic f127 (39) 39
tumors (39) 39
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Investigational New Drugs, ISSN 0167-6997, 10/2011, Volume 29, Issue 5, pp. 1029 - 1037
Purpose To evaluate the antitumor activity of SP1049C, a novel P-glycoprotein targeting micellar formulation of doxorubicin, consisting of doxorubicin and two... 
SP1049C | Adenocarcinoma | Resistance | Gastroesophageal cancer | Medicine & Public Health | Oncology | Pharmacology/Toxicology | Gastric cancer | Doxorubicin | Esophageal cancer | METAANALYSIS | CARDIA | ADVANCED ESOPHAGOGASTRIC CANCER | RANDOMIZED-TRIAL | FLUOROURACIL | DOCETAXEL | EPIRUBICIN | CISPLATIN | ONCOLOGY | ADVANCED GASTRIC-CANCER | PHARMACOLOGY & PHARMACY | MULTIDRUG-RESISTANCE | Doxorubicin - therapeutic use | Adenocarcinoma - pathology | Esophagogastric Junction - physiopathology | Humans | Middle Aged | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - therapeutic use | ATP-Binding Cassette, Sub-Family B, Member 1 - antagonists & inhibitors | Molecular Targeted Therapy | Esophageal Neoplasms - pathology | Poloxamer - adverse effects | Adenocarcinoma - physiopathology | Antineoplastic Agents - adverse effects | Doxorubicin - analogs & derivatives | Adult | Female | Kaplan-Meier Estimate | Poloxamer - analogs & derivatives | Esophagogastric Junction - pathology | Adenocarcinoma - drug therapy | Poloxamer - therapeutic use | Stroke Volume | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Esophageal Neoplasms - physiopathology | Aged | Neoplasm Staging | Esophageal Neoplasms - drug therapy | Doxorubicin - adverse effects | Complications and side effects | Dosage and administration | Drug therapy | Gastrointestinal cancer | Stomach cancer | Studies | Clinical trials | Pharmacology | Head & neck cancer | Cancer therapies | Index Medicus
Journal Article
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 6/2011, Volume 19, Issue 6, pp. 833 - 841
Chemotherapy-induced peripheral neuropathy (CIPN) is a troublesome chronic symptom that has no proven pharmacologic treatment. The purpose of this double-blind... 
Pain Medicine | Rehabilitation Medicine | Nursing | Medicine & Public Health | Topical gel | Oncology | CIPN | BAK-PLO | Nursing Management/Nursing Research | MANAGEMENT | AMITRIPTYLINE | EFFICACY | RAT | PHASE-II | KETAMINE | VISUAL ANALOG SCALE | PAIN SYNDROMES | PACLITAXEL NEUROTOXICITY | CISPLATIN | ONCOLOGY | HEALTH CARE SCIENCES & SERVICES | REHABILITATION | Excitatory Amino Acid Antagonists - therapeutic use | Peripheral Nervous System Diseases - chemically induced | GABA-B Receptor Agonists - therapeutic use | Humans | Middle Aged | Male | GABA-B Receptor Agonists - adverse effects | Administration, Cutaneous | GABA-B Receptor Agonists - administration & dosage | Ketamine - administration & dosage | Baclofen - adverse effects | Ketamine - adverse effects | Lecithins - chemistry | Antineoplastic Agents - adverse effects | Female | Ketamine - therapeutic use | Excitatory Amino Acid Antagonists - adverse effects | Baclofen - therapeutic use | Poloxamer - chemistry | Adrenergic Uptake Inhibitors - adverse effects | Adrenergic Uptake Inhibitors - therapeutic use | Double-Blind Method | Gels | Baclofen - administration & dosage | Excitatory Amino Acid Antagonists - administration & dosage | Treatment Outcome | Amitriptyline - adverse effects | Adrenergic Uptake Inhibitors - administration & dosage | Aged | Amitriptyline - therapeutic use | Drug Combinations | Peripheral Nervous System Diseases - drug therapy | Amitriptyline - administration & dosage | Amitriptyline | Chemotherapy | Lecithin | Baclofen | Clinical trials | Research | Cancer | Side effects | Drug therapy | Neurological disorders | Index Medicus
Journal Article
Physiology & Behavior, ISSN 0031-9384, 01/2017, Volume 168, pp. 11 - 19
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 06/2017, Volume 255, pp. 258 - 269
Journal Article